PURETECH HEALTH : Vedanta Biosciences Announces Successful Phase 1a/1b Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead Product Candidate, VE303

Press/Media

Period	4 Oct 2018

Media coverage

Title	PURETECH HEALTH : Vedanta Biosciences Announces Successful Phase 1a/1b Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead Product Candidate, VE303
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	4/10/18
URL	https://www.marketscreener.com/PURETECH-HEALTH-PLC-22619613/news/Puretech-Health-Vedanta-Biosciences-Announces-Successful-Phase-1a-1b-Demonstrating-Safety-Tolerab-27366933/
Persons	Jeremiah Faith